Clinical Trial Update: Neoadjuvant Iparomlimab/Tuvonralimab Plus CAPEOX Versus Iparomlimab/Tuvonralimab Plus CAPEOX and Propranolol for Locally Advanced pMMR Colon Cancer: A Prospective, Single-Center, Multi-Cohort Study [Phase 2]

View source ↗

Summary

Phase II neoadjuvant trial for locally advanced pMMR colon cancer comparing Iparomlimab/Tuvonralimab plus CAPEOX with or without propranolol; the study is not y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)
• Propranolol (propranolol)
• Tuvonralimab (tuvonralimab)
• iparomlimab

Snippet

Sponsor: Sun Yat-sen University | Conditions: Colon Cancer (Stage II &Amp; III), Immunotherapy | Phase 2 | Status: NOT_YET_RECRUITING